Search citation statements
Paper Sections
Citation Types
Publication Types
Relationship
Authors
Journals
ABSTRACT. Pulmonary embolism (PE) is the third most common acute cardiovascular disease after myocardial infarction and stroke, and results in thousands of deaths each year. Improvements in MRI accuracy are ongoing with the use of parallel imaging for angiography techniques and pulmonary perfusion. This, associated with other potential advantages of MRI (e.g. a radiation free method and better safety profile of MR contrast media), reinforces its use. The aim of this paper is to perform a pictorial review of the principal findings of MRI in acute PE. Acute PE can manifest itself as complete arterial occlusion and the affected artery may be enlarged. We report the main vascular and parenchymal signs, and an overview of current literature regarding accuracy, limitations and technical aspects is provided. Diagnostic strategies for pulmonary embolism (PE) have evolved over the last few decades with the development of new diagnostic methods. Initially, the time required for an MR examination and the lack of MR-compatible monitoring devices hindered the broad clinical acceptance of this method. Recently, significant technical developments in pulmonary MR angiography have occurred. Improvements include the use of parallel imaging, view-sharing, time-resolved echo-shared angiography [1, 2] and pulmonary perfusion. These techniques have shortened the acquisition time of MR angiography, improved spatial resolution and made it less susceptible to motion artefacts. In addition to classical MR angiography, other sequence types have been developed for more rapid acquisition of images and additional functional information.The increased use of multidetector CT (MDCT) scanning has raised concerns about overall radiation exposure to the population, and has emphasised the need in the radiology community for optimised scanning protocols [3]. MRI does not require ionising radiation, or iodated contrast media, and is associated with less renal impairment than MDCT. Thus, MRI appears to be the ideal imaging modality for use in ruling out PE.The aim of this paper is to provide a pictorial review of MRI in PE diagnosis, and assess its accuracy through a review of the literature. MRI techniqueThe proposed MRI protocol for PE diagnosis consists of real-time MR, MR perfusion imaging and MR angiography [3]. This basic evaluation protocol can be easily extended to match individual demands like the assessment of right and/or left ventricular function or the visualisation of the abdominal/pelvic and lower limb veins. The examination protocol first addresses fast overview sequences that ensure short examination times for use with patients in critical condition. Subsequently, the protocol presents a more comprehensive evaluation of the pulmonary arteries, for use with patients with less serious conditions ( Table 1). The total time of acquisition is therefore dependent on the depth of the evaluation and lasts anywhere between 3 and 20 min. The achieved diagnostic accuracy is, at each step, balanced against the patient's condition (30-50 s for tra...
ABSTRACT. Pulmonary embolism (PE) is the third most common acute cardiovascular disease after myocardial infarction and stroke, and results in thousands of deaths each year. Improvements in MRI accuracy are ongoing with the use of parallel imaging for angiography techniques and pulmonary perfusion. This, associated with other potential advantages of MRI (e.g. a radiation free method and better safety profile of MR contrast media), reinforces its use. The aim of this paper is to perform a pictorial review of the principal findings of MRI in acute PE. Acute PE can manifest itself as complete arterial occlusion and the affected artery may be enlarged. We report the main vascular and parenchymal signs, and an overview of current literature regarding accuracy, limitations and technical aspects is provided. Diagnostic strategies for pulmonary embolism (PE) have evolved over the last few decades with the development of new diagnostic methods. Initially, the time required for an MR examination and the lack of MR-compatible monitoring devices hindered the broad clinical acceptance of this method. Recently, significant technical developments in pulmonary MR angiography have occurred. Improvements include the use of parallel imaging, view-sharing, time-resolved echo-shared angiography [1, 2] and pulmonary perfusion. These techniques have shortened the acquisition time of MR angiography, improved spatial resolution and made it less susceptible to motion artefacts. In addition to classical MR angiography, other sequence types have been developed for more rapid acquisition of images and additional functional information.The increased use of multidetector CT (MDCT) scanning has raised concerns about overall radiation exposure to the population, and has emphasised the need in the radiology community for optimised scanning protocols [3]. MRI does not require ionising radiation, or iodated contrast media, and is associated with less renal impairment than MDCT. Thus, MRI appears to be the ideal imaging modality for use in ruling out PE.The aim of this paper is to provide a pictorial review of MRI in PE diagnosis, and assess its accuracy through a review of the literature. MRI techniqueThe proposed MRI protocol for PE diagnosis consists of real-time MR, MR perfusion imaging and MR angiography [3]. This basic evaluation protocol can be easily extended to match individual demands like the assessment of right and/or left ventricular function or the visualisation of the abdominal/pelvic and lower limb veins. The examination protocol first addresses fast overview sequences that ensure short examination times for use with patients in critical condition. Subsequently, the protocol presents a more comprehensive evaluation of the pulmonary arteries, for use with patients with less serious conditions ( Table 1). The total time of acquisition is therefore dependent on the depth of the evaluation and lasts anywhere between 3 and 20 min. The achieved diagnostic accuracy is, at each step, balanced against the patient's condition (30-50 s for tra...
Background Pulmonary embolism (PE) is a serious condition and has a clinical dilemma in diagnosis. Computed tomography pulmonary angiography (CTPA) is a gold standard in its diagnosis, but MRI has proven a good role in PE diagnosis. Aim The aim of this work was to evaluate the role of noncontrast magnetic resonance pulmonary angiography (MRPA) imaging in diagnosis of acute PE using CTPA as a gold standard. Patients and methods In total, 25 patients with PE confirmed by CTPA were included in this study. All patients underwent computed tomography angiography and noncontrast MRPA on the same day or within three consecutive days. The results were compared and statistically analyzed. Results The mean age of the study group was 46.4 ± 13.5 years. Females represent 60% (15/25) and males represent 40% (10/25). The per-vessel sensitivity of noncontrast MRPA reached to about 100% with specificity 100% at the level of the main trunk, right and left main pulmonary arteries down to segmental arteries. The sensitivity for right subsegmental branches was 25% and left subsegmental branches was 33.3%. Conclusion The noncontrast MRPA has a reasonable sensitivity and specificity in the diagnosis of PE, especially in major branches. So, it can be used as an alternative to the computed tomography angiography, especially when the computed tomography angiography and the use of gadolinium are contraindicated.
Background: Increased right ventricle-to-left ventricle (RV/LV) ratio on computed tomography pulmonary angiography (CTPA) has been reported as a poor prognostic indicator in patients with acute pulmonary embolism (PE). It has also been reported that pulmonary vein sign (PVS) on CTPA is a rare finding of PE. Objectives: To evaluate PVS on CTPA and unenhanced magnetic resonance imaging (MRI) in patients with PE suspicion. We also aimed to investigate the relationship between the severity of PE and presence of PVS, RV/LV ratio and combination of these two on unenhanced MRI. Patients and Methods: One-hundred-twelve patients with PE suspicion who underwent CTPA and unenhanced-MRI [steady state free precession (SSFP)] within the first 48-hours constituted the study group. All CTPA images were evaluated for the presence, location and severity of PE by observer-1. Two observers (observer-2 and 3), independently evaluated unenhanced-MR images for the presence of PVS without knowing the results of CTPA. Then, these 2 observers reviewed the CTPA and MRI images together with observer-4 to reach the final consensus for the presence of PVS and measurement of RV/LV ratio. Cohen's Kappa analysis was used to assess the agreement between observers. Relationship between the mean PE index and imaging findings (PVS, RV/LV) were calculated.Results: Presence of PVS on CT or MRI is significantly correlated with PE index and patients with PVS had more severe PE than those without. Presence of both PVS and RV/LV ratio > 1 on MRI indicates more severe pulmonary embolism than absence of PVS or RV/LV ratio > 1. There was a very good agreement for the detection of PVS between two observers on unenhanced MRI. Conclusion: PVS on CTPA or unenhanced MRI can be used as a sign of severe PE and it may also be an indicator of right heart dysfunction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.